Human Intelligence at the heart of your ATMP development journey

More than a classical…

C D M O A
ATMP Expert
Analytics-driven
Alliance

A Multi-Expertise Center ready to operate any engineered Cell Drug Product.

          • Lymphoïd Cells: T Cells and NK Cells
          • Myeloïd Cells: Dendritic Cells
          • Adult Stem Cells & iPS Cells

When Industrialization respect Cell Drug Product Characterization

          • SAFETY: Cellsecure
          • IDENTITY: Cellnature
          • POTENCY: Cellfeature

From Discovery to Clinical Set-up, our pluridisciplinary Team begins your best ally to secure access to market.

Bridging the gap between R&D Project and clinical Development

News

News

28.09.2022

EMERCell & Cell-Easy sign a Strategic Agreement for the Scale-up and Manufacturing of NK-001

TOULOUSE, France & MONTPELLIER, France _ September 22, 2022 Emercell […]

Read More

Congress

18.08.2022

Cell-Easy to participate at Phacilitate Advanced Therapies Europe meeting in London, August 31 – September 1, 2022

Cell-Easy Business Director Guillaume Lay will attend the Advanced Therapies […]

Read More

Press

28.02.2022

The OPTI-STEM consortium led by Cell-Easy to democratize access to cell therapy in France and Europe

Toulouse, La Madeleine, Nancy, France – 28 February, 2022 The […]

Read More

Press

07.02.2022

Virginie Duel joins Cell-Easy as Head of Quality Control.

The Cell-Easy management team is very pleased to announce the […]

Read More
View all

Our partners

THEY TRUST US !

Contact

  • Tel : +33 534 276 550
  • Address : Cell-Easy SAS, 4 bis avenue Hubert Curien, 31100 Toulouse, France
  • Mail : info@cell-easy.com
European leading CDMO company specialized in large volume industrialized production of GMP approved cell products